Tumour immunity: effector response to tumour and role of the microenvironment.
about
Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatmentThe linear no-threshold relationship is inconsistent with radiation biologic and experimental dataAnti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapyHave lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?The Role of Stroma in Tumor DevelopmentMast cells as a potential prognostic marker in prostate cancerThe Yin and Yang of Toll-like receptors in cancerTrabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironmentLinks demystified: Periodontitis and cancerMechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infectionReflections upon human cancer immune responsiveness to T cell-based therapyAn immunologic portrait of cancerTargeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeDeciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast CancerReactive oxygen species a double-edged sword for mesotheliomaEmerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyIntratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas.Tumors as organs: complex tissues that interface with the entire organismSystemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer modelThe evaluation of metallothionein expression in nasal polyps with respect to immune cell presence and activity.Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.Adult stem cels and their nichesChimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.The inflammatory microenvironment in colorectal neoplasia.Prognostic value of PLR in various cancers: a meta-analysis.Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer.New insights into the role of EMT in tumor immune escape.Roles of CXCL5 on migration and invasion of liver cancer cellsImmune cells: plastic players along colorectal cancer progressionMultifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumorsImplications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel diseaseActivated macrophages in the tumour microenvironment-dancing to the tune of TLR and NF-kappaBEx vivo expansion of human CD8+ T cells using autologous CD4+ T cell helpImmunotherapy for metastatic solid cancersThe relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome StudyThe modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen.In Vitro Administration of Gold Nanoparticles Functionalized with MUC-1 Protein Fragment Generates Anticancer Vaccine Response via Macrophage Activation and Polarization Mechanism.Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.
P2860
Q21328704-4BD851F2-0D17-48E4-912A-AAF51DBF7E67Q24649840-BA91BFCF-49DA-4313-964E-1344B0558517Q24655930-8CB5F670-DA37-485C-9C04-FFCDEC390A20Q26747695-26D589D2-6817-434F-A37B-01F94C75D8A7Q26801843-0B3FED1E-1D3B-416F-B286-AB077A96A0E4Q26827773-AF43A327-A99B-4970-95A9-4292417C0773Q26851526-3DC0409B-2A2F-48E0-92D7-108BD2E76378Q26851658-2BC14168-2D3D-4C41-91BE-3B2E20FEF261Q26865599-754EF760-F147-4296-9B2B-93DB6BCD49F3Q27002467-73E388C3-554F-41E7-97F4-93E0B983D582Q27004674-5BF99996-6AF2-4AE7-BBFA-8BC174AA73A8Q27028000-F9FF67FD-E83D-4B07-AD42-FEC86EC561FEQ28066522-619CD362-461D-4156-9FCF-726D4483002AQ28072448-A7268AF8-8BE0-46C6-A58C-BC1BDEEDB542Q28392665-668F56D1-A84C-4225-90E5-69E647A930F0Q30438965-9627232A-AB61-44E5-9FCF-59BCDF7A9E75Q30466624-5D068E29-F32C-4315-A2AE-22397293B349Q30495528-41C30C8D-AAB1-405C-A511-7E62DFB749D6Q33479314-2ECA29EC-23E2-4F76-92B5-CC7B24B633E9Q33517133-664132EE-0898-44EB-BDBF-82CB03994DE6Q33538899-290F3858-E494-4334-B5C3-A888B7723AD2Q33575734-FD0F9438-F117-424C-A45B-D67A534714CBQ33607691-437E6B5A-FC40-4390-A90D-DF9D84C46A64Q33671322-D8E319F2-72D1-46CE-BE84-B677EA47F267Q33750137-6C30E4C9-F244-4179-A590-A5A57FD4742BQ33797695-28B511C1-5F0A-4459-B537-A280DECB6D5DQ33812584-D61CF15E-DBC7-49B6-B251-FA041CF1F335Q33844782-C38BF76E-90D1-4CFA-8379-187E4BE54CC8Q33869781-F0071732-3393-4DF4-A9FA-D67AC0F913A4Q33897910-F77132DD-3185-4CA6-899F-85A101E6B7C8Q33985586-136CC6E0-31FB-4EC4-97BE-AEF2FE209118Q34052580-ED39581E-FBAE-40CE-ADD8-8633559B2356Q34052630-B201CB0C-EDD4-4440-9689-D0EC4EAF648DQ34111440-67FE0E46-9B67-463E-97D9-9088D9087E27Q34141754-F4E1398E-99C8-4969-AB32-70314CCDFB29Q34219970-1C96970F-BE24-460D-A2D1-D9E0CE888FDBQ34253740-3C1AF3E1-0420-4478-89F4-FD5F2E6F11BDQ34384335-2FCFF964-53F8-4EDB-937B-14A9237A693EQ34477424-203192CB-844A-4EE8-B7CA-4FC722EE3DABQ34570874-AEB543F2-42F4-4913-8FB4-947BFD24992C
P2860
Tumour immunity: effector response to tumour and role of the microenvironment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumour immunity: effector response to tumour and role of the microenvironment.
@en
Tumour immunity: effector response to tumour and role of the microenvironment.
@nl
type
label
Tumour immunity: effector response to tumour and role of the microenvironment.
@en
Tumour immunity: effector response to tumour and role of the microenvironment.
@nl
prefLabel
Tumour immunity: effector response to tumour and role of the microenvironment.
@en
Tumour immunity: effector response to tumour and role of the microenvironment.
@nl
P2093
P1433
P1476
Tumour immunity: effector response to tumour and role of the microenvironment.
@en
P2093
A Karolina Palucka
Francesco M Marincola
Pedro Romero
P304
P356
10.1016/S0140-6736(08)60241-X
P407
P577
2008-02-13T00:00:00Z